Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...

The National Kidney Foundation will celebrate the recipients of its top awards — including two NKyians — at its annual Dining ...

Theories suggest UTI and constipation are related, but one does not necessarily cause the other at this stage in research. Learn about treating both here.

For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An innovative new device could change everything.

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Brenda Jagatic, BScN, RN, CDCES, about the prevalence of erectile ...